TODAY'S NEWS

RSNA 2018: Mammography Screening Beyond ...

Women aged 75 years and older may benefit from con...

---

RSNA 2018: Breast Cancer Risk-Based Mamm...

A new, large-scale study of more than 5 million ma...

---

RSNA 2018: Preliminary Results of Primar...

Cryoablation has shown early indications of effect...

---

Eicosapentaenoic Acid and Aspirin in Pre...

In a trial reported in The Lancet by Hull et al, n...

---

Reducing Infections in Patients With AML...

In a report in the Journal of Oncology Practice, M...

More News From Today

EDITORIALS & COMMENTARY

Trametinib in Metastatic Melanoma

Trametinib is a MEK inhibitor approved both as a single agent and in combination with dabrafenib...

---

Neratinib for HER2-Positive Breast Cancer

The treatment of breast cancer has been revolutionized by the development of HER2-targeted treatments...

---

Collaboration and Oral Chemotherapy Education

Providing comprehensive chemotherapy education to patients in a busy clinical practice setting can be challenging...

---

Painful Nodules and Recurrent Fever in ALL

Mr. S is a 39-year-old Hispanic male with a diagnosis of Philadelphia chromosome–negative ALL...

---

Thank You to Our Peer Reviewers!

We would like to acknowledge everyone who completed peer reviews for JADPRO in the past year...

More Editorials & Commentary

PREVIOUS HIGHLIGHTS

SELECT Trial: Adjuvant Erlotinib in Rese...

In a phase II trial reported in the Journal of Cli...

---

ASCO and Friends of Cancer Research Appl...

ASCO and Friends of Cancer Research applaud the Na...

---

FDA Pipeline: New Priority Reviews, Desi...

The ASCO Post summarizes recent drug designat...

---

Primary Resistance to Immune Checkpoint ...

In a study reported in JAMA Oncology, Cohen et al ...

---

POEMS/SWOG Intergroup S0230 Study on Pre...

In the long-term follow-up of the POEMS/SWOG Inter...

More Highlights

LATEST TWEETS

---

---

---

---

More Tweets